Reduction of submental fat Patients achieved statistically significant reduction in submental fat thickness as measured from baseline vs. placebo based on MRI (p<0.05 and p<0.001, week 16 and 32, ...
Deoxycholic acid, an endogenously produced bile acid, has emerged as a pioneering non‐surgical treatment for reducing submental fat. By selectively inducing adipocytolysis—the breakdown of fat ...
REROVOT, Israel, March 3, 2025 /PRNewswire/ -- Raziel Therapeutics, a pharmaceutical company developing next-generation novel prescription products for the medical aesthetics market, announces phase 3 ...
Please provide your email address to receive an email when new articles are posted on . The combination treatment decreased fat in the submental area and increased volume in the jawline. Submental ...
Cutia Therapeutics (HK:2487) has released an update. Cutia Therapeutics has announced the completion of a Phase II clinical trial for CU-20401, a novel drug targeting submental fat reduction. This ...
The Phase 2 study enrolled 96 participants and demonstrated strong results. At four weeks after the final treatment, 69.70% of participants in the 25 mg/mL treatment group achieved at least a ...
Please provide your email address to receive an email when new articles are posted on . After 12 weeks of application, overall skin firmness improved by 61% from baseline. Skin texture improved by 59% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback